KPV Oral (tablets)
The anti-inflammatory tripeptide KPV as a 500 mcg tablet. The right form for an angry gut; not a whole-body or skin tool.
What it is
KPV oral is the three-amino-acid calming fragment of a natural hormone, pressed into a 500 mcg tablet you swallow. It lands on the gut lining, which is exactly where the colitis research gave it, so for a bowel that is inflamed and reactive the tablet is the natural form. For skin or for inflammation elsewhere in the body, it is the wrong route.
The tablet is for people whose gut is inflamed rather than damaged: colitis-type flares, IBS that leans toward urgency and cramping, the raw, reactive bowel left behind by food poisoning or a long antibiotic course, and the people on a biologic who want a gentle adjunct and have cleared it with their gastroenterologist. It is also the easy second half of the oral gut pairing with BPC-157 oral, which handles lining repair while KPV handles the inflammation on top.
KPV is quiet. Most people notice nothing dramatic; what they notice over two to four weeks is that the gut is less reactive, with fewer cramping, urgent mornings and less of the bloated, sore feeling after eating. If a flare is in progress, two tablets a day for the first week or two is what people do before dropping to one. It will not do anything for a sore tendon, it will not clear acne from the inside, and if nothing has shifted by week six it is not going to.
One tablet a day is the standard tier, two tablets (together or morning and evening) the higher, run for 8 to 12 weeks, or as long as you need it. There is no tolerance or build-up reason to cycle it, so there is no set break: stop or taper once the gut has settled and see whether the calm holds, and go back on if it flares. Food does not matter much for KPV, unlike BPC-157 oral, which wants an empty stomach; most people take both together first thing in the morning for simplicity. A bottle of 100 is 100 days at one a day, or 50 at two, which makes a full 12-week run about one bottle. The mistakes are expecting a skin effect from a tablet, quitting at two weeks, and using the tablet as a reason to stop prescribed IBD treatment.
On evidence: animal 3, human 0. Oral KPV reduced colitis severity, weight loss and inflammatory markers in several mouse models, including when it was simply added to drinking water, by getting into the cells of the gut lining and switching off NF-kB, the master switch for inflammatory signals like TNF-alpha and IL-6. That is a route-matched animal result, which is better than most oral peptides can claim. There is no human trial for either route, and nobody knows how much of a tablet reaches the bloodstream.
Skip the tablet if skin is the goal: KPV for acne, eczema or wound redness is used topically or injected, and the injectable KPV record covers that. Skip it for whole-body inflammation or joint complaints, where injectable KPV or a healing stack makes more sense. If lining damage is the bigger problem than inflammation, BPC-157 oral or the BPC-157 + KPV blend covers both. And if you have diagnosed Crohn's or ulcerative colitis, KPV is an add-on at most; LL-37 is listed as an alternative here, but it is an antimicrobial peptide with a different job and no gut-flare data.
What people use it for
Gut inflammation
Some evidenceOral KPV reduced colitis severity, weight loss and inflammatory markers in several mouse models, including when given in drinking water or in nanoparticle carriers. It is taken up by gut-lining cells and dials down NF-kB signaling. Animal only, but the route matches how you would take it, which is why the tablet is the form for the gut.
Skin and wounds
Early daysKPV's acne, eczema and wound-healing data come from topical and injected use, not tablets. People hoping a swallowed KPV will calm their skin are using the wrong form; the injectable KPV record and its topical notes are where to look.
Whole-body inflammation
Early daysNobody has measured how much of a swallowed KPV tablet reaches the bloodstream in a person. Since the tablet's animal data was about the gut lining, and alpha-MSH fragments are broken down quickly, assume the tablet is local to the gut and use the injectable if you want a systemic effect.
How people use it
Safety, in brief
Things people sometimes notice
- A few days of looser or firmer stools while the gut adjusts
- Very few side effects reported at all; KPV is one of the gentlest peptides here
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
- Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model
- Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis